Clinical renal transplantation: where are we now, what are our key challenges?
about
Development and validation of an LC-MS/MS assay for the quantification of the trans-methylation pathway intermediates S-adenosylmethionine and S-adenosylhomocysteine in human plasmaBP, cardiovascular disease, and death in the Folic Acid for Vascular Outcome Reduction in Transplantation trial.Measuring health related quality of life (hrqol) in renal transplant patients: psychometric properties and cross-cultural adaptation of kidney transplant questionnaire (ktq-25) in persian.Role of glycemic control on hospital-related outcomes in patients with diabetes mellitus undergoing renal transplantation.
P2860
Clinical renal transplantation: where are we now, what are our key challenges?
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh
2010年學術文章
@zh-hant
name
Clinical renal transplantation: where are we now, what are our key challenges?
@en
Clinical renal transplantation: where are we now, what are our key challenges?
@nl
type
label
Clinical renal transplantation: where are we now, what are our key challenges?
@en
Clinical renal transplantation: where are we now, what are our key challenges?
@nl
prefLabel
Clinical renal transplantation: where are we now, what are our key challenges?
@en
Clinical renal transplantation: where are we now, what are our key challenges?
@nl
P1476
Clinical renal transplantation: where are we now, what are our key challenges?
@en
P2093
J R Chapman
P356
10.1016/J.TRANSPROCEED.2010.09.017
P407
P433
P577
2010-11-01T00:00:00Z